Buch, Englisch, 492 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 768 g
Buch, Englisch, 492 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 768 g
ISBN: 978-1-62703-836-2
Verlag: Humana Press
Of the thousands of biomarkers that are currently being discovered, relatively few are being validated for further applications, and the potential of a biomarker can be quite difficult to evaluate. To aid in this imperative research, Dr. Kewal K. Jain’s thoroughly describes many different types of biomarkers and their discovery using various "-omics" technologies, such as proteomics and metabolomics, along with the background information needed for the evaluation of biomarkers as well as the essential procedures for their validation and use in clinical trials. With biomarkers described first according to technologies and then according to various diseases, this detailed book features the key correlations between diseases and classifications of biomarkers, which provides the reader with a guide to sort out current and future biomarkers.
Comprehensive and cutting-edge, serves as a vital guide to furthering ourunderstanding of biomarkers, which, by facilitating the combination of therapeutics with diagnostics, promise to play an important role in the development of personalized medicine, one of the most important emerging trends in healthcare today.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
Weitere Infos & Material
Technologies for Discovery of Biomarkers.- Biomarkers and Molecular Diagnostics.- Biomarkers for Drug Discovery and Development.- Role of Biomarkers in Health Care.- Biomarkers of Cancer.- Biomarkers of Disorders of the Nervous System.- Biomarkers of Cardiovascular Disorders.- Biomarkers and Personalized Medicine.- Regulatory Issues.
